Regenicin CEO to Present at OneMedForum Business Development and Finance in San Francisco
Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs, will participate in the 4th Annual OneMedForum on January 11-13, 2011 in San Francisco. Randall McCoy, CEO of Regenicin, will present the company's core concept and business model for bringing new regenerative medicine products to market.
The Forum will bring together some of the most promising emerging medtech and life science companies with strategic and financial investors focused on companies and new technologies. Focused panel sessions will also help CEOs connect with financial and strategic investors involved in specific sectors and will include networking and breakout sessions.
The conference is considered the healthcare finance community's largest gathering of the year. More information about the conference can be found at http://www.onemedplace.com/forum/.
Read more: PR Newswire Regenicin CEO to Present at OneMedForum Business Development and Finance ...